SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-002863
Filing Date
2019-02-07
Accepted
2019-02-07 16:15:14
Documents
1
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3160
  Complete submission text file 0000899243-19-002863.txt   4564
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MAGENTA THERAPEUTICS 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
COOKE MICHAEL P. (Reporting) CIK: 0001741288 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38541 | Film No.: 19575347